ELLO vs GNE

ELLO exhibits significant financial fragility, highlighted by a weak Piotroski F-Score of 3/9 and a concerning Debt/Equity ratio of 3.85, which is more than double the sector average. While the company shows strong gross margins and revenue growth, these are offset by negative net profit margins and a volatile earnings track record. The current valuation is highly stretched with a Price/Sales ratio of 8.11, creating a sharp disconnect between the stock's recent 1-year price surge and its underlying fundamental health.

GNE exhibits a strong deterministic health profile with a Piotroski F-Score of 8/9 and negligible debt (D/E 0.05), yet it is fundamentally overvalued. The current price of $13.79 significantly exceeds both the Graham Number ($6.99) and the growth-based Intrinsic Value ($2.03). While revenue growth remains robust at 23.6%, a sharp decline in earnings (-32% YoY) and a payout ratio exceeding 100% indicate an unsustainable dividend and deteriorating profitability. The combination of bearish technicals, insider selling, and consistent earnings misses suggests a high risk of price correction.